Evidence map›Paper›PMID 31606237›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2019

Genetics and ESKD Disparities in African Americans.

Ebele M Umeukeje, Bessie A Young

Open access · greenAbstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ebele M UmeukejeDivision of Nephrology, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.
Bessie A YoungNephrology, Hospital and Specialty Medicine and Center for Innovation for Veteran-Centered and Value Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, WA; Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, WA. Electronic address: youngb@uw.edu.
Vanderbilt University Medical Center · USVA Puget Sound Health Care System · US

Funding

Building Interdisciplinary Research Careers in Women's HealthK12HD043483 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTMANN, KATHERINE E, MAJOR, AMY S · 2002 to 2023
$10.3M
Community-Based Evaluation of APOL1 Genetic Testing in African AmericansR01HG007879 · NHGRI · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., YOUNG, BESSIE ANN · 2015 to 2017
$2.1M
Patient-centered Approach To Improving Dialysis Adherence in African AmericansK23DK114566 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI UMEUKEJE, EBELE M · 2018 to 2022
$929k
NHGRI NIH HHS R01 HG007879NICHD NIH HHS K12 HD043483NIDDK NIH HHS K23 DK114566
6 · The paper itself

Abstract

African Americans have a 2- to 4-fold greater incidence of end-stage kidney disease (ESKD) than whites, which has long raised the possibility of a genetic cause for this disparity. Recent advances in genetic studies have shown a causal association of polymorphisms at the apolipoprotein L1 gene (APOL1) with the markedly increased risk for the nondiabetic component of the overall disparity in ESKD in African Americans. Although APOL1-associated kidney disease is thought to account for a substantial proportion of ESKD in African Americans, not all the increased risk for ESKD is accounted for, and a complete cataloging of disparities in genetic causes of ESKD eludes our current understanding of genetic-associated kidney disease. Genetic testing aids the screening, diagnosis, prognosis, and treatment of diseases with a genetic basis. Widespread use of genetic testing in clinical practice is limited by the small number of actionable genetic variants, limited health literacy of providers and patients, and underlying complex ethical, legal, and social issues. This perspective reviews racial and ethnic differences associated with genetic diseases and the development of ESKD in African Americans and discusses potential uncertainties associated with our current understanding of penetrance of genetically linked kidney disease and population-attributable risk percent.

Indexed as

Apolipoprotein L1Black or African AmericanCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenetic TestingHealthcare DisparitiesHealth Status DisparitiesHumansKidney Failure, ChronicKidney TransplantationMaleNeeds AssessmentRenal DialysisUnited StatesApolipoprotein L1African AmericansAfrican ancestryangiotensin-converting enzyme (ACE)angiotensin II type 1 receptor (AT1)angiotensinogen (AGT)apolipoprotein L1 (APOL1)diabetes mellitusdiabetic nephropathyEnd-stage kidney disease (ESKD)genetic riskglutathione-S-transferease Mu 1 (GSTM1)hypertensionkidney disease disparitiesnephrin (NPHS1)racial disparitiesrenin angiotensin and aldosterone system (RAAS)reviewrisk allelesalt sensitivitysickle cell disease (SCD)single-nucleotide polymorphism (SNP)uromodulin (UMOD)

Identifiers

PMID31606237
PMCPMC7373097
OpenAlexW2979644627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.